FDA's Focus On Competition May Boost FTC Enforcement
The U.S. Food and Drug Administration's growing focus on competition problems in the pharmaceutical sector could lead to policy changes making it easier for generics to come to market, while also...To view the full article, register now.
Already a subscriber? Click here to view full article